<DOC>
	<DOCNO>NCT01299012</DOCNO>
	<brief_summary>Evaluating use Liraglutide patient Type 1 Diabetes .</brief_summary>
	<brief_title>Liraglutide Additional Treatment Patients With Type 1 Diabetes Mellitus</brief_title>
	<detailed_description>This investigation retrospective chart review type 1 diabetic treat liraglutide . The study conduct Diabetes-Endocrinology Center WNY Millard Fillmore Hospital , affiliate State University New York Buffalo . Study Population : 40 patient type 1 diabetes treatment either continuous subcutaneous insulin infusion ( CSII ; also know insulin pump ) multiple ( four ) injection insulin per day continuous glucose monitoring system ( CGMS ) include study . These patient type 1 diabetes treat liraglutide addition insulin . The investigator would retrospectively review chart evaluate decrease fast , postprandial overall mean glucose concentration . The investigator compare mean fasting , mean weekly glucose standard deviation weekly blood glucose concentration record continuous glucose monitoring prior follow one week 12 week treatment liraglutide daily . In addition , investigator compare time spend glucose concentration &gt; 150 200mg/dl &lt; 70 &lt; 40 mg/dl . HbA1c level 12 week treatment liraglutide daily compare .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 1</mesh_term>
	<mesh_term>Liraglutide</mesh_term>
	<criteria>Type 1 Diabetes Mellitus Type 2 Diabetes Mellitus</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>